BioMed Research International
Volume 2016, Article ID 9513037, 14 pages
http://dx.doi.org/10.1155/2016/9513037
miR-155 as a Biomarker in B-Cell Malignancies
1Department of Haematology, Aalborg University Hospital, Hobrovej 18-22, 9100 Aalborg, Denmark
2Department of Haematology, Aarhus University Hospital, Tage-Hansens Gade 2, 8000 Aarhus C, Denmark
3Department of Mathematical Sciences, Aalborg University, Fredrik Bajers Vej 5, 9100 Aalborg, Denmark
4Department of Clinical Medicine, Aalborg University, Fredrik Bajers Vej 5, 9100 Aalborg, Denmark
5Clinical Cancer Research Center, Aalborg University Hospital, Hobrovej 18-22, 9100 Aalborg, Denmark
Received 23 December 2015; Accepted 3 April 2016
Academic Editor: Stefan Costinean
Copyright © 2016 Hanne Due et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Supplementary Material
Table S1. Search strategy in PubMed and EMBASE PubMed and EMBASE were systemically searched for eligible articles using the listed search terms.
Figure S1. Flow diagram of study selection. The search for eligible articles from the databases PubMed and EMBASE was finalized November 18th 2015. The systematic search revealed 606 articles after removal of duplicates, which subsequently were manually screened based on title and abstract. Not English articles, reviews, and articles not focusing on B-cell malignancies, miR-155 as a biomarker or therapeutic target were excluded. Remaining articles were screened by full-text and 53 articles were included in the review.